Germantown, Maryland — According to state and local economic development sources QIAGEN Sciences plans to invest $104,092,050.00 to build out 188,206 square feet of new space in Germantown. The company plans to occupy the new space at 19300 Germantown Rd in Germantown, on or about February 1, 2022. According to the company website QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows.

To learn more about QIAGEN Sciences, visit http://www.qiagen.com/

Company Contact:
Thierry Bernard, Chief Executive Officer
thierry.bernard@qiagen.com
https://www.linkedin.com/in/thierry-bernard-616154/
240-686-7700

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved